SOPH Form 144: Insider sale notice for 380 RSUs

SOPH affiliate reported proposed and recent insider sales of common stock and restricted stock units.

Rhea-AI Filing Summary

SOPH affiliate reported proposed and recent insider sales of common stock and restricted stock units. The notice lists a proposed sale of 380 restricted stock units dated 02/18/2026. It also records prior 10b5-1 sales: 381, 2,085, 636, and 380 shares on the dates shown in the filing.

Insights

Securities Compliance Counsel

Form 144 shows routine affiliate sale notices under a 10b5-1 plan and a proposed RSU sale.

The filing lists a proposed disposition of 380 restricted stock units dated 02/18/2026 and multiple completed 10b5-1 sales in the prior three months with exact share counts and dates.

Timing and cash‑flow recipients are as disclosed in the entries; the filing serves as a regulatory notice of these insider transactions and does not by itself change company fundamentals.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for SOPH report?

The filing reports proposed and completed insider sales of common stock and RSUs. It lists a proposed sale of 380 RSUs dated 02/18/2026 and several 10b5-1 sales with share counts and dates.

Who executed the 10b5-1 sales shown in SOPH's filing?

The filing records 10b5-1 sales attributed to an individual named Manuela Valente. It shows specific trade dates and share counts for those listed sales in the excerpt.

How many shares were sold in the recent 10b5-1 trades?

The excerpt lists completed 10b5-1 sales of 381, 2,085, 636, and 380 shares on the dates provided. Each line includes the sale date and share count.

Does the Form 144 state who receives proceeds from these sales?

The filing lists the selling person and the share amounts but does not specify proceeds recipients beyond the named seller entries. Cash‑flow payees are not detailed in the excerpt.

Are the proposed RSUs in the filing being sold by the issuer or the holder?

The entry labels the securities as Restricted Stock Units with the disposition type Issuer and a quantity of 380 dated 02/18/2026, per the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002009280
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	MANUELA VALENTE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	380	1835.40	67847058	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/18/2026	Restricted Stock Units	Issuer			380	02/18/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	01/20/2026	380	2040.98
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	01/06/2026	636	3015.72
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	01/05/2026	2085	9603.93
10b5-1 Sales for MANUELA VALENTE La Piece 12 ch-1180 Rolle V8 00000	Common	12/19/2025	381	1764.45

144: Remarks and Signature

Remarks
Date of Notice	02/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Manuela Valente
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)